Overview
Julia Cooperman is a Palliative Medicine provider in New York, New York. Dr. Cooperman has been practicing medicine for over 9 years.
Her clinical research consists of co-authoring 3 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
Locations
622 W 168th St, New York, NY 10032
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Paul Glare is a Palliative Medicine provider in New York, New York. Dr. Glare is highly rated in 1 condition, according to our data. His top area of expertise is Chronic Pain.
Icahn School Of Medicine At Mount Sinai
Christie Mulholland is a Palliative Medicine provider in New York, New York. Dr. Mulholland is highly rated in 1 condition, according to our data. Her top area of expertise is Opioid Induced Constipation.
North Shore Health System Medical Faculty Group Practice Inc
Nagashree Seetharamu is an Oncologist and a Palliative Medicine provider in New Hyde Park, New York. Dr. Seetharamu is highly rated in 28 conditions, according to our data. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
We do not have enough information to identify the Areas of Expertise for this provider.